Tang, X.; Guo, D.; Yang, X.; Chen, R.; Jiang, Q.; Zeng, Z.; Li, Y.; Li, Z.
Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas. Cells 2022, 11, 3655.
https://doi.org/10.3390/cells11223655
AMA Style
Tang X, Guo D, Yang X, Chen R, Jiang Q, Zeng Z, Li Y, Li Z.
Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas. Cells. 2022; 11(22):3655.
https://doi.org/10.3390/cells11223655
Chicago/Turabian Style
Tang, Xin, Dongfang Guo, Xi Yang, Rui Chen, Qingming Jiang, Zhen Zeng, Yu Li, and Zhenyu Li.
2022. "Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas" Cells 11, no. 22: 3655.
https://doi.org/10.3390/cells11223655
APA Style
Tang, X., Guo, D., Yang, X., Chen, R., Jiang, Q., Zeng, Z., Li, Y., & Li, Z.
(2022). Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas. Cells, 11(22), 3655.
https://doi.org/10.3390/cells11223655